- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06865313
Functional Evaluation After Maxillectomy and Scapular Free Flap Reconstruction
Total or Subtotal Maxillectomy with Scapular Free Flap Reconstruction: Airway Management, Aesthetic and Functional Results
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Lyon, France, 69004
- Croix Rousse Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patient with maxillary sinus tumor
- Treated by maxillectomy with free scapula tip flap reconstruction
- 18 years of age or older
Exclusion Criteria:
- Reconstruction failure
- Carcinomatous recurrence and/or further progression impacting quality of life
- Death
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
patients studied
patients with malignant or benign maxillary sinus tumors managed by total maxillectomy and free scapular flap reconstruction
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
time to resumption of oral feeding
Time Frame: through study completion, an average of 15 days
|
time to resumption of oral feeding after the surgery, measuring in days
|
through study completion, an average of 15 days
|
|
duration of hospitalization in a continuing care unit
Time Frame: through study completion, an average of 15 days
|
hospitalization in a continuing care unit after the surgery, measuring in days
|
through study completion, an average of 15 days
|
|
Tracheotomy
Time Frame: through study completion, an average of 15 days
|
need to do a tracheotomy during or after the surgery, qualitative outcome (yes or no)
|
through study completion, an average of 15 days
|
|
Hospitalisation time
Time Frame: through study completion, an average of 15 days
|
Duration of the whole hospitalisation in the ENT unit, measuring in days
|
through study completion, an average of 15 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Swallowing assessment with the Functional Oral Intake Scale
Time Frame: through study completion, an average of 2 years
|
Swallowing was assessed using the Functional Oral Intake Scale (FOIS).
Scores ranged from one (no oral intake) to seven (normal diet with no change in texture), with a high score indicating good swallowing function.
|
through study completion, an average of 2 years
|
|
Aesthetic evaluation
Time Frame: through study completion, an average of 2 years
|
A subjective patient assessment of the aesthetic result was carried out using the appearance subcategory of the University of Washington Quality of Life Questionnaire (UW-QOL v4).
There are five possible responses, each scored at 0, 25, 50, 75 and 100.
A score of 0 represents the worst possible aesthetic result, and a score of 100 the best possible result.
|
through study completion, an average of 2 years
|
|
Quality of Life assessment using European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-C30 (version 3.0) and European Organisation for Research and Treatment of Cancer Head & Neck 43 questionnaires.
Time Frame: through study completion, an average of 2 years
|
The QLQ-C30 is a general quality-of-life questionnaire specific to oncological pathology and intended for all cancer patients regardless of location. It comprises a central questionnaire for assessing 5 functions (physical, cognitive, social, limitations in daily activities and psychological), 9 symptoms and overall health. To this questionnaire can be added modules specific to a cancer site, such as the EORTC QLQ-H&N43 for head and neck cancers. Responses to both questionnaires are then transformed to produce a score ranging from 0 to 100. For the functional scales and the global health scale, a high score represents a good level of functioning, while a high score on the symptom scales indicates a high level of symptoms and/or problems. |
through study completion, an average of 2 years
|
|
Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire
Time Frame: through study completion, an average of 2 years
|
Functional assessment of the upper limb was performed using the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire.
This is a subjective self-assessment questionnaire of the overall functional capacity of both upper limbs.
The score ranges from 0 to 100.
Higher scores indicate an inability to perform tasks, great difficulty in doing them, or significant symptoms.
|
through study completion, an average of 2 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Carine FUCHSMANN, Hospice Civil de Lyon
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023-05-022-CS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Maxillary Sinus Squamous Cell Carcinoma
-
Cairo UniversityCompletedDental Implant | Maxillary Sinus | Maxillary Sinus Lift | Maxillary Sinus ElevationEgypt
-
Glenn J. HannaCoherus Biosciences, Inc.RecruitingSquamous Cell Carcinoma | Paranasal Sinus Neoplasms | Sinonasal Cancer | Sinonasal Undifferentiated Carcinoma | Locally Advanced Head and Neck CancerUnited States
-
Mashhad University of Medical SciencesCompletedDisorder of Maxillary Sinus | Maxillary Sinus Floor AugmentationIran, Islamic Republic of
-
The Dental Hospital of Zhejiang University School...RecruitingSinus Floor Augmentation | Maxillary SinusChina
-
Kırıkkale UniversityCompleted
-
Cairo UniversityUnknown
-
University of Sao PauloCompleted
-
Cairo UniversityUnknownMaxillary Sinus
-
University of MinnesotaNovaBone Products, LLCCompletedSinus Floor Augmentation | Maxillary SinusUnited States
-
Tokat Gaziosmanpasa UniversityCompletedMaxillary Sinus Augmentation | Posterior Maxillary AtrophyTurkey (Türkiye)